Tavs Qvist

2.0k total citations
48 papers, 800 citations indexed

About

Tavs Qvist is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Tavs Qvist has authored 48 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 23 papers in Epidemiology and 11 papers in Infectious Diseases. Recurrent topics in Tavs Qvist's work include Cystic Fibrosis Research Advances (20 papers), Mycobacterium research and diagnosis (17 papers) and Infectious Diseases and Mycology (9 papers). Tavs Qvist is often cited by papers focused on Cystic Fibrosis Research Advances (20 papers), Mycobacterium research and diagnosis (17 papers) and Infectious Diseases and Mycology (9 papers). Tavs Qvist collaborates with scholars based in Denmark, United Kingdom and United States. Tavs Qvist's co-authors include Niels Høiby, Terese L. Katzenstein, T. Pressler, Karen Damgaard-Pedersen, Marianne Skov, David Taylor‐Robinson, Mette Kolpen, Peter Østrup Jensen, Inger Hee Mabuza Mathiesen and Thomas Bjarnsholt and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Stroke and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Tavs Qvist

43 papers receiving 781 citations

Peers

Tavs Qvist
Pei Yee Tiew Singapore
Allan L. Truant United States
Elliott C. Dasenbrook United States
S A Berger Israel
Gary M. Albers United States
Stacey L. Martiniano United States
D.M. Boothe United States
C.H. Webb United Kingdom
Pei Yee Tiew Singapore
Tavs Qvist
Citations per year, relative to Tavs Qvist Tavs Qvist (= 1×) peers Pei Yee Tiew

Countries citing papers authored by Tavs Qvist

Since Specialization
Citations

This map shows the geographic impact of Tavs Qvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tavs Qvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tavs Qvist more than expected).

Fields of papers citing papers by Tavs Qvist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tavs Qvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tavs Qvist. The network helps show where Tavs Qvist may publish in the future.

Co-authorship network of co-authors of Tavs Qvist

This figure shows the co-authorship network connecting the top 25 collaborators of Tavs Qvist. A scholar is included among the top collaborators of Tavs Qvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tavs Qvist. Tavs Qvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qvist, Tavs, Andrew Bush, & Michal Shteinberg. (2025). Water, Water Everywhere, Nor Any Drop to Drink: Beware of Mycobacteria. American Journal of Respiratory and Critical Care Medicine. 211(5). 691–692.
2.
Qvist, Tavs, Bibi Uhre Nielsen, Hanne Vebert Olesen, et al.. (2024). Close monitoring and early intervention: management principles for cystic fibrosis in Denmark. Apmis. 132(4). 223–235. 7 indexed citations
3.
Marthin, June K., Johanna Raidt, Tavs Qvist, et al.. (2024). Long-Term Lung Function and Pseudomonas aeruginosa Infection in Genotyped Primary Ciliary Dyskinesia. Annals of the American Thoracic Society. 22(2). 216–225. 2 indexed citations
4.
Barr, Hugh, et al.. (2024). P089 FORMaT: Finding the Optimal Regimen for Mycobacterium abscessus Treatment. A randomised, multi-arm, adaptive platform trial. Journal of Cystic Fibrosis. 23. S94–S94. 1 indexed citations
5.
Nielsen, Susanne Dam, Mette Frahm Olsen, Tavs Qvist, et al.. (2024). Cardiac Structure and Function in People with Cystic Fibrosis. Journal of Cystic Fibrosis. 23(6). 1138–1145.
6.
Katzenstein, Terese L., Daniel Faurholt‐Jepsen, Tavs Qvist, et al.. (2023). Antimicrobial resistance of Pseudomonas aeruginosa in a cystic fibrosis population after introduction of a novel cephalosporin/β‐lactamase inhibitor combination. Apmis. 131(8). 419–425. 1 indexed citations
7.
Harboe, Zitta Barrella, Lene Fogt Lundbo, Jon Gitz Holler, et al.. (2023). Implementation of a vaccination clinic for adult solid organ transplant candidates: A single-center experience. Vaccine. 41(45). 6637–6644. 5 indexed citations
8.
Crone, C., Omid Rezahosseini, Hans Henrik Lawaetz Schultz, et al.. (2022). Achromobacter spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients. Pathogens. 11(2). 181–181. 9 indexed citations
9.
Mauch, Renan Marrichi, Peter Østrup Jensen, Tavs Qvist, et al.. (2022). Adaptive Immune Response to Mycobacterium abscessus Complex (MABSC) in Cystic Fibrosis and the Implications of Cross-Reactivity. Frontiers in Cellular and Infection Microbiology. 12. 858398–858398. 3 indexed citations
10.
Kolpen, Mette, Kasper Nørskov Kragh, Daniel Faurholt‐Jepsen, et al.. (2022). Bacterial biofilms predominate in both acute and chronic human lung infections. Thorax. 77(10). 1015–1022. 85 indexed citations
11.
Qvist, Tavs, Daniela K Schlüter, Peter J. Diggle, et al.. (2018). Seasonal fluctuation of lung function in cystic fibrosis: A national register-based study in two northern European populations. Journal of Cystic Fibrosis. 18(3). 390–395. 8 indexed citations
12.
Qvist, Tavs, et al.. (2018). Antibody response against Mycobacterium avium complex in cystic fibrosis patients measured by a novel IgG ELISA test. Journal of Cystic Fibrosis. 18(4). 516–521. 10 indexed citations
13.
Qvist, Tavs, David Taylor‐Robinson, Elisabeth Waldmann, et al.. (2015). Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis. Journal of Cystic Fibrosis. 15(3). 380–385. 103 indexed citations
14.
Qvist, Tavs, Işık Somuncu Johansen, T. Pressler, et al.. (2014). Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria – experiences from the Danish Cystic Fibrosis cohort study. BMC Infectious Diseases. 14(1). 655–655. 18 indexed citations
15.
Skov, Marianne, Tacjana Pressler, Jens Lykkesfeldt, et al.. (2014). The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection — A pilot study. Journal of Cystic Fibrosis. 14(2). 211–218. 28 indexed citations
16.
Qvist, Tavs, Marita Gilljam, Bodil Jönsson, et al.. (2014). Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia. Journal of Cystic Fibrosis. 14(1). 46–52. 90 indexed citations
17.
Qvist, Tavs, Susan Cowan, Christian Graugaard, & Marie Helleberg. (2014). High Linkage to Care in a Community-Based Rapid HIV Testing and Counseling Project Among Men Who Have Sex With Men in Copenhagen. Sexually Transmitted Diseases. 41(3). 209–214. 27 indexed citations
18.
Omland, Lars Haukali, et al.. (2010). Risk of high‐level viraemia in HIV‐infected patients on successful antiretroviral treatment for more than 6 months. HIV Medicine. 11(7). 457–461. 3 indexed citations
19.
Berg, Ronan M. G., Gitte Irene Strauss, Flemming Tofteng, et al.. (2009). Circulating levels of vasoactive peptides in patients with acute bacterial meningitis. Intensive Care Medicine. 35(9). 1604–1608. 13 indexed citations
20.
Møller, Kirsten, et al.. (2005). Cerebral output of cytokines in patients with pneumococcal meningitis*. Critical Care Medicine. 33(5). 979–983. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026